Skip to Content

Halazepam Pregnancy and Breastfeeding Warnings

Halazepam is also known as: Paxipam

Halazepam Pregnancy Warnings

Halazepam has been assigned to pregnancy category D by the FDA. An increased risk of congenital malformations in humans has been associated with use of other benzodiazepines. Withdrawal symptoms have been reported in neonates whose mothers took other benzodiazepines during pregnancy. There are no controlled data in human pregnancy. Halazepam should only be given during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Halazepam Breastfeeding Warnings

There are no data on the excretion of halazepam into human milk. Other benzodiazepines are excreted into human milk and have been reported to have clinically significant effects on the breast-fed infant. Those reported effects include sedation, lethargy, and weight loss. The American Academy of Pediatrics has no position on the use of halazepam during lactation but has classified other benzodiazepines as "drugs whose effect on nursing infants is unknown but may be of concern".

See references

References for pregnancy information

  1. Bracken MB, Holford TR "Exposure to prescribed drugs in pregnancy and association with congenital malformations." Obstet Gynecol 58 (1981): 336-44
  2. Koren G, Pastuszak A, Ito S "Drugs in pregnancy." N Engl J Med 338 (1998): 1128-37
  3. Scanlon JW "Effect of benzodiazepines in neonates." N Engl J Med 292 (1975): 649
  4. "Product Information. Paxipam (halazepam)." Schering Laboratories, Kenilworth, NJ.

References for breastfeeding information

  1. Roberts RJ, Blumer JL, Gorman RL, et al "American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk." Pediatrics 84 (1989): 924-36
  2. Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50
  3. Wesson DR, Camber S, Harkey M, Smith DE "Diazepam and desmethyldiazepam in breast milk." J Psychoactive Drugs 17 (1985): 55-6

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.